SEARCH

SEARCH BY CITATION

References

  • Ahn, K., Johnson, D.S. & Cravatt, B.F.2009. Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discov4, 763784.
  • Alger, B.E. 2002. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol68, 247286.
  • Argaw, A., Duff, G., Zabouri, N., Cécyre, B., Chainé, N., Cherif, H., Tea, N., Lutz, B., Ptito, M. & Bouchard, J.F.2011. Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidance. J Neurosci31, 14891499.
  • Bertrand, T., Augé, F., Houtmann, J., Rak, A., Vallée, F., Mikol, V., Berne, P.F., Michot, N., Cheuret, D., Hoornaert, C. & Mathieu, M.2010. Structural basis for human monoglyceride lipase inhibition. J Mol Biol396, 663673.
  • Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M.G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.J., Gangadharan, U., Hobbs, C., Di Marzo, V. & Doherty, P.2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol163, 463468.
  • Blankman, J.L., Simon, G.M. & Cravatt, B.F.2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol14, 13471356.
  • Cabral, G.A., Raborn, E.S., Griffin, L., Dennis, J. & Marciano-Cabral, F.2008. CB2 receptors in the brain: role in central immune function. Br J Pharmacol153, 240251.
  • Chanda, P.K., Gao, Y., Mark, L., Btesh, J., Strassle, B.W., Lu, P., Piesla, M.J., Zhang, M.Y., Bingham, B., Uveges, A.et al.2010. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol78, 9961003.
  • De Petrocellis, L. & Di Marzo, V.2009. Role of endocannabinoids and endovanilloids in Ca2+ signalling. Cell Calcium45, 611624.
  • Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T. & Kunos, G.2001. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature410, 822825.
  • Di Marzo, V., Bisogno, T. & De Petrocellis, L.2007. Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol14, 741756.
  • Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S. & Piomelli, D.2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA99, 1081910824.
  • Dinh, T.P., Kathuria, S. & Piomelli, D.2004. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol66, 12601264.
  • Fiskerstrand, T., H’mida-Ben Brahim, D., Johansson, S., M’zahem, A., Haukanes, B.I., Drouot, N., Zimmermann, J., Cole, A.J., Vedeler, C., Bredrup, C.et al.2010. Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet87, 410417.
  • Freund, T.F., Katona, I. & Piomelli, D.2003. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev83, 10171066.
  • Gao, Y., Vasilyev, D.V., Goncalves, M.B., Howell, F.V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.Y., Strassle, B.W., Lu, P.et al.2010. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci30, 20172024.
  • Hashimotodani, Y., Ohno-Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., Araishi, K., Shin, H.S. & Kano, M.2005. Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron45, 257268.
  • Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. & Rice, K.C.1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci11, 563583.
  • Hohmann, A.G. 2007. Inhibitors of monoacylglycerol lipase as novel analgesics. Br J Pharmacol150, 673675.
  • Hurst, D.P., Grossfield, A., Lynch, D.L., Feller, S., Romo, T.D., Gawrisch, K., Pitman, M.C. & Reggio, P.H.2010. A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor. J Biol Chem28, 1795417964.
  • Jung, K.M., Astarita, G., Zhu, C., Wallace, M., Mackie, K. & Piomelli, D.2007. A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. Mol Pharmacol72, 612621.
  • Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M.2009. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev89, 309380.
  • Karlsson, M., Contreras, J.A., Hellman, U., Tornqvist, H. & Holm, C.1997. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem272, 2721827223.
  • Katona, I., Urbán, G.M., Wallace, M., Ledent, C., Jung, K.M., Piomelli, D., Mackie, K. & Freund, T.F.2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci26, 56285637.
  • Keimpema, E., Barabas, K., Morozov, Y.M., Tortoriello, G., Torii, M., Cameron, G., Yanagawa, Y., Watanabe, M., Mackie, K. & Harkany, T.2010. Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J Neurosci30, 1399214007.
  • Kinsey, S.G., Long, J.Z., O’Neal, S.T., Abdullah, R.A., Poklis, J.L., Boger, D.L., Cravatt, B.F. & Lichtman, A.H.2009. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther330, 902910.
  • Labar, G., Bauvois, C., Borel, F., Ferrer, J.L., Wouters, J. & Lambert, D.M.2010a. Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. Chembiochem11, 218227.
  • Labar, G., Wouters, J. & Lambert, D.M.2010b. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr Med Chem17, 25882607.
  • Laitinen, J.T. 2004. [35S]GTPγS autoradiography: a powerful functional approach with expanding potential for neuropharmacological studies on receptors coupled to Gi family of G proteins. Curr Neuropharmacol2, 191206.
  • Lambert, D.M. & Fowler, C.J.2005. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem48, 50595087.
  • Li, F., Fei, X., Xu, J. & Ji, C.2009. An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines. Mol Biol Rep36, 691696.
  • Lichtman, A.H., Blankman, J.L. & Cravatt, B.F.2010. Endocannabinoid overload. Mol Pharmacol78, 993995.
  • Long, J.Z., Li, W., Booker, L., Burston, J.J., Kinsey, S.G., Schlosburg, J.E., Pavón, F.J., Serrano, A.M., Selley, D.E., Parsons, L.H., Lichtman, A.H. & Cravatt, B.F.2009. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol5, 3744.
  • Ludányi, A., Hu, S.S., Yamazaki, M., Tanimura, A., Piomelli, D., Watanabe, M., Kano, M., Sakimura, K., Maglóczky, Z., Mackie, K., Freund, T.F. & Katona, I.2011. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience174, 5063.
  • Mackie, K. 2006. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol46, 101122.
  • Marrs, W.R., Blankman, J.L., Horne, E.A., Thomazeau, A., Lin, Y.H., Coy, J., Bodor, A.L., Muccioli, G.G., Hu, S.S., Woodruff, G.et al.2010. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci13, 951957.
  • Max, D., Hesse, M., Volkmer, I. & Staege, M.S.2009. High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors. Cancer Sci100, 23832389.
  • Nomura, D.K., Long, J.Z., Niessen, S., Hoover, H.S., Ng, S.W. & Cravatt, B.F.2010. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell140, 4961.
  • Palomäki, V.A.B., Lehtonen, M., Savinainen, J.R. & Laitinen, J.T.2007. Visualization of 2-arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography. J Neurochem101, 972981.
  • Pan, B., Wang, W., Long, J.Z., Sun, D., Hillard, C.J., Cravatt, B.F. & Liu, Q.S.2009. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerollipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther331, 591597.
  • Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P., Di Marzo, V., Elphick, M.R., Greasley, P.J., Hansen, H.S., Kunos, G., Mackie, K., Mechoulam, R. & Ross, R.A.2010. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev62, 588631.
  • Petrosino, S. & Di Marzo, V.2010. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Investig Drugs11, 5162.
  • Piomelli, D. 2003. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci4, 873884.
  • Saario, S.M. & Laitinen, J.T.2007. Therapeutic potential of endocannabinoid-hydrolyzing enzyme inhibitors. Basic Clin Pharmacol Toxicol101, 287293.
  • Saario, S.M., Savinainen, J.R., Laitinen, J.T., Järvinen, T. & Niemi, R.2004. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol67, 13811387.
  • Saario, S.M., Salo, O.M., Nevalainen, T., Poso, A., Laitinen, J.T., Järvinen, T. & Niemi, R.2005. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem Biol12, 649656.
  • Savinainen, J.R., Yoshino, M., Minkkilä, A., Nevalainen, T. & Laitinen, J.T.2010. Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique. Anal Biochem399, 132134.
  • Schlosburg, J.E., Blankman, J.L., Long, J.Z., Nomura, D.K., Pan, B., Kinsey, S.G., Nguyen, P.T., Ramesh, D., Booker, L., Burston, J.J.et al.2010. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci13, 11131119.
  • Straiker, A., Hu, S.S., Long, J.Z., Arnold, A., Wager-Miller, J., Cravatt, B.F. & Mackie, K.2009. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol76, 12201227.
  • Sugiura, T., Kishimoto, S., Oka, S. & Gokoh, M.2006. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res45, 405446.
  • Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., Sakimura, K. & Kano, M.2010. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron65, 320327.
  • Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M. & Watanabe, M.2007. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci27, 36633676.
  • Yoshida, T., Uchigashima, M., Yamasaki, M., Katona, I., Yamazaki, M., Sakimura, K., Kano, M., Yoshioka, M. & Watanabe, M.2011. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci USA108, 30593064.